| Cardiac Imaging and Diagnostics | Lifetime | 96 | US 56 | 99.82 |
| Lipoproteins and Cardiovascular Health | Lifetime | 44 | US 26 | 99.75 |
| Cardiovascular Disease and Adiposity | Lifetime | 77 | US 52 | 99.49 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 105 | US 47 | 99.51 |
| Cardiac Health and Mental Health | Lifetime | 71 | US 45 | 99.23 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 317 | US 151 | 99.07 |
| Cardiovascular Health and Risk Factors | Lifetime | 56 | US 38 | 99.05 |
| Cardiovascular Function and Risk Factors | Lifetime | 444 | US 245 | 99.19 |
| Acute Myocardial Infarction Research | Lifetime | 266 | US 135 | 99.10 |
| Blood Pressure and Hypertension Studies | Lifetime | 378 | US 169 | 98.85 |
| Cancer, Lipids, and Metabolism | Lifetime | 645 | US 316 | 97.68 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 553 | US 230 | 97.75 |
| Advanced X-ray and CT Imaging | Lifetime | 978 | US 412 | 96.11 |
| Biomarkers in Disease Mechanisms | Lifetime | 158 | US 42 | 94.29 |
| Pharmaceutical Economics and Policy | Lifetime | 438 | US 208 | 95.07 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 770 | US 190 | 87.31 |
| Aortic Thrombus and Embolism | Lifetime | 304 | US 130 | 81.27 |
| Sex and Gender in Healthcare | Lifetime | 723 | US 375 | 73.58 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 77 | US 35 | 98.03 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 233 | US 90 | 96.05 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 104 | US 63 | 94.73 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 768 | US 211 | 95.24 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 289 | US 77 | 93.50 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 535 | US 132 | 86.85 |
| Cardiac Health and Mental Health | 2021-2025 | 912 | US 263 | 81.60 |
| Fatty Acid Research and Health | 2021-2025 | 588 | US 117 | 75.80 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 937 | US 324 | 73.50 |
| Aortic Thrombus and Embolism | 2021-2025 | 93 | US 26 | 59.87 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 582 | US 102 | 56.99 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 830 | US 71 | 38.38 |
